Brief: Selecta Biosciences Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing
Oct 25 (Reuters) - Selecta Biosciences Inc SELB.O :
* SELECTA BIOSCIENCES INC FILES FOR MIXED SHELF OF UP TO
$200
MILLION – SEC FILING
Further company coverage: SELB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cartesian Therapeutics
See all newsBrief: Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis
Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cartesian Therapeutics Q2 net income steady
Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million
Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview